Tower Research Capital LLC (Trc) Taro Pharmaceutical Industries LTD Transaction History

Tower Research Capital LLC (Trc)

$3.68 Billion
Q3 2024

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$40.97 - $43.33 $10,734 - $11,352	-262 Reduced 68.77%	119 $5,000
Q4 2023 Feb 13, 2024	BUY	$32.77 - $42.31 $2,359 - $3,046	72 Added 23.3%	381 $15,000
Q3 2023 Nov 14, 2023	SELL	$35.46 - $40.13 $25,743 - $29,134	-726 Reduced 70.14%	309 $11,000
Q2 2023 Aug 14, 2023	BUY	$24.24 - $40.97 $24,676 - $41,707	1,018 Added 5988.24%	1,035 $39,000
Q1 2023 May 09, 2023	BUY	$23.0 - $31.59 $391 - $537	17 New	17 $0
Q3 2022 Nov 10, 2022	SELL	$28.74 - $39.9 $948 - $1,316	-33 Reduced 23.57%	107 $3,000
Q2 2022 Aug 15, 2022	BUY	$35.0 - $43.59 $4,760 - $5,928	136 Added 3400.0%	140 $5,000
Q1 2022 May 12, 2022	SELL	$43.12 - $50.3 $1,336 - $1,559	-31 Reduced 88.57%	4 $0
Q4 2021 Feb 14, 2022	BUY	$47.6 - $65.0 $1,428 - $1,950	30 Added 600.0%	35 $2,000
Q3 2021 Nov 15, 2021	SELL	$62.34 - $73.38 $150,800 - $177,506	-2,419 Reduced 99.79%	5 $0
Q2 2021 Aug 16, 2021	BUY	$70.26 - $76.64 $48,128 - $52,498	685 Added 39.39%	2,424 $174,000
Q1 2021 May 17, 2021	BUY	$70.48 - $79.95 $100,574 - $114,088	1,427 Added 457.37%	1,739 $128,000
Q4 2020 Feb 16, 2021	SELL	$54.4 - $73.42 $4,188 - $5,653	-77 Reduced 19.79%	312 $23,000
Q3 2020 Nov 16, 2020	BUY	$54.41 - $68.2 $10,609 - $13,299	195 Added 100.52%	389 $21,000
Q2 2020 Aug 13, 2020	SELL	$61.66 - $70.16 $2,836 - $3,227	-46 Reduced 19.17%	194 $13,000
Q1 2020 May 15, 2020	SELL	$59.35 - $88.73 $103,269 - $154,390	-1,740 Reduced 87.88%	240 $15,000
Q4 2019 Feb 07, 2020	BUY	$74.18 - $97.92 $139,680 - $184,383	1,883 Added 1941.24%	1,980 $174,000
Q3 2019 Nov 05, 2019	SELL	$75.36 - $86.57 $279,811 - $321,434	-3,713 Reduced 97.45%	97 $7,000
Q2 2019 Aug 13, 2019	BUY	$83.92 - $108.88 $266,529 - $345,802	3,176 Added 500.95%	3,810 $325,000
Q1 2019 May 14, 2019	SELL	$85.97 - $108.09 $643,399 - $808,945	-7,484 Reduced 92.19%	634 $69,000
Q4 2018 Feb 14, 2019	BUY	$78.25 - $107.92 $519,110 - $715,941	6,634 Added 447.04%	8,118 $687,000
Q3 2018 Nov 13, 2018	SELL	$97.82 - $116.09 $31,106 - $36,916	-318 Reduced 17.65%	1,484 $146,000
Q2 2018 Aug 15, 2018	SELL	$97.62 - $120.59 $365,782 - $451,850	-3,747 Reduced 67.53%	1,802 $208,000
Q1 2018 May 15, 2018	BUY	$95.91 - $107.26 $244,954 - $273,942	2,554 Added 85.28%	5,549 $548,000
Q4 2017 Feb 09, 2018	BUY	$104.5 - $126.38 $199,908 - $241,764	1,913 Added 176.8%	2,995 $314,000
Q3 2017 Nov 14, 2017	BUY	$97.26 - $116.2 $105,235 - $125,728	1,082	1,082 $122,000

Others Institutions Holding TARO

# of Institutions

Shares Held

17K

Call Options Held

Put Options Held

View Full List

About TARO PHARMACEUTICAL INDUSTRIES LTD

Ticker TARO
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 37,584,600
Description
Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, develops, manufactures, and markets prescription and over-the-counter pharmaceutical products in the United States, Canada, Israel, and internationally. The company also develops and manufactures active pharmaceutical ingredients primarily for use in its finished dosage...

More about TARO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account